Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_provenance.
- NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_assertion description "[We investigated genetically affected leukemic cells in FIP1L1-PDGFRA+ chronic eosinophilic leukemia (CEL) and in BCR-ABL1+ chronic myeloid leukemia (CML), two myeloproliferative disorders responsive to imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_provenance.
- NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_assertion evidence source_evidence_literature NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_provenance.
- NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_assertion SIO_000772 17215855 NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_provenance.
- NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_assertion wasDerivedFrom befree-20140225 NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_provenance.
- NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_assertion wasGeneratedBy ECO_0000203 NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP431302.RA1gdDrmwEtU3pUDnB4zji9g0SoetIdygFDFeiqwhMfnk130_provenance.